Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.48 USD | -0.29% | -.--% | -.--% |
2023 | EV Biologics, Inc. Closes A $500,000 Interest-Free Loan | CI |
2023 | Ev Biologics Completes Production of Cutting-Edge Msc Exosome-Based Therapeutic | CI |
Financials (USD)
Sales 2016 | 42.64M | Sales 2017 | 9.51M | Capitalization | 6.09M |
---|---|---|---|---|---|
Net income 2016 | -53M | Net income 2017 | -7M | EV / Sales 2016 | 0.69 x |
Net Debt 2016 | 9M | Net Debt 2017 | 10.03M | EV / Sales 2017 | 1.7 x |
P/E ratio 2016 |
-0.38
x | P/E ratio 2017 |
-0.82
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 23.58% |
1 day | -0.29% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 18-10-28 |
Jason Sanders
BRD | Director/Board Member | 46 | 20-08-30 |
William Bossung
BRD | Director/Board Member | - | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 18-10-28 |
William Bossung
BRD | Director/Board Member | - | 18-12-02 |
Jason Sanders
BRD | Director/Board Member | 46 | 20-08-30 |
1st Jan change | Capi. | |
---|---|---|
+19.81% | 47.84B | |
-2.89% | 15.44B | |
-1.00% | 15.27B | |
-15.75% | 10.38B | |
+26.55% | 8.75B | |
+105.28% | 8.61B | |
-0.30% | 7.84B | |
-8.75% | 7.39B | |
+23.60% | 6.64B |
- Stock Market
- Equities
- YECO Stock
- YECO Stock